The goal of this project is to understand how the endoplasmic reticulum (ER) of barrier epithelial cells lining the intestine may operate to innately sense the microbial environment, and how this may impact gut immunity, host defense, and the pathogenesis of Inflammatory Bowel Disease (IBD). Intestinal epithelial cells are highly susceptible to perturbations in the Unfolded Protein Response (UPR) and/or Endoplasmic Reticulum (ER) stress, a fundamental biological response originating from an alteration of processes normally occurring within the ER lumen. Genetic studies have revealed several ER stress/UPR- associated genes as risk factors for IBD, and they are associated with alterations in host-microbe interactions in the intestine and with the activation of key proinflammatory pathways. Remarkably, the intestinal epithelium of IBD patients often shows evidence of ER stress, implicating a paradigm of ER stress-related inflammation in IBD. We recently discovered the novel mechanism that IRE1a, the most ancient of the three mammalian ER stress sensors, acts as a pattern-recognition molecule in innate immunity to sense bacterial and viral proteins entering the ER from the lumenal environment (Cell Host Microbe, May 2013). Previously, there were no known mechanisms of innate immunity located in the ER (or Golgi) of host cells, though all other membrane- bound compartments and the cytosol are equipped with such factors. We believe the IRE1 pathway may act as a generalized mechanism of innate immune surveillance in the human intestine. Mammals, for example, have a second isoform of IRE1 (IRE1) whose expression is restricted to the heavily microbial colonized epithelium of the gut, and whose absence predisposes to colitis. We have preliminary evidence that IRE1 can act like IRE1a in pattern-recognition; and with enhanced activity in the innate immune signaling pathway. We hypothesize that IRE1, or both IRE1a and IRE1, may act to sense the gut microflora to set the immunologic tone (or response) of the intestinal mucosa in ways relevant to health and disease. In this grant, we will determine the mechanism and function of IRE1 as a pattern-recognition molecule in intestinal epithelial cells, and elucidate the physiologic consequence of the IRE1 signaling pathway for sensing the gut microflora and affecting mucosal immunity.

Public Health Relevance

We propose studies to elucidate a new pathway for innate immune surveillance of gut microbes. The IRE1 sensing pathway originates from within the endoplasmic reticulum (ER) of the polarized epithelial cells that line the intestine, and which form the most direct interface with commensal bacteria and the most resistive component of the intestinal barrier. We propose that the IRE1 pathway explains one mechanism for how the 'normal' gut microbiota communicate with the host to affect mucosal immunity and the inflammatory response.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
1K01DK102828-01A1
Application #
8903614
Study Section
Kidney, Urologic and Hematologic Diseases D Subcommittee (DDK)
Program Officer
Saslowsky, David E
Project Start
2015-04-01
Project End
2015-08-14
Budget Start
2015-04-01
Budget End
2015-08-14
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Children's Hospital Boston
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code